In this week’s Food Exec Brief, we’re covering:
A University of Chicago study estimates mandatory UPF labeling would cost the industry at least $14.2 billion annually, with 72% of packaged foods qualifying and roughly $60 per household passing to consumers.
The World Bank projects global food prices will rise roughly 10% in 2026, then increase another 7% in 2027, driven by energy costs and supply disruptions from the ongoing Middle East conflict.
GLP-1-driven demand for high-protein yogurt outpaced Danone’s US manufacturing capacity, triggering supply disruptions and a leadership overhaul as the company heads into 2027.
The UPF labeling cost totals $14 billion
A University of Chicago study estimated the price of mandatory UPF labeling as at least $14.2 billion in annual industry costs. That estimate includes $9.5 billion for reformulation, $4.5 billion for substitute ingredients, and $200 million for federal administration and relabeling. The study found that 72.3% of nearly 450,000 products in the USDA’s branded food database would qualify as UPFs, covering 51% of grocery spending. About $8.1 billion of that total would pass through to consumers, roughly $60 per household. And $14.2 billion is the floor. The study excludes an estimated $1 billion in lost domestic agriculture revenue and up to $9.7 billion in higher food import costs. (Learn more)
Public pressure is ahead of policy and hard to dismiss as a fringe movement. An Annenberg Public Policy Center survey found 80% of US adults support requiring UPF labels on packaged foods, 79% support removing highly processed foods from school lunches, and 75% support increased regulation of chemical additives. Only 26% of Americans identify as MAHA supporters, but support for the specific policy proposals averages 73% across the general population. (Learn more)
The definition itself is still unpublished, which makes planning challenging. The FDA sent a proposed UPF definition to the White House as a white paper in August but hasn’t released it publicly. More than 100 nutrition and medical experts sent a letter to OMB on October 23 urging its release. The University of Chicago study had to use a May 2026 Healthy Eating Research definition because the FDA’s version remains under wraps. Without a final definition, manufacturers can’t target reformulation dollars, lock in ingredient sourcing decisions, or model which products cross the line. (Learn more)
The input cost outlook is getting more expensive
The World Bank projects global food prices will rise roughly 10% in 2026, then another 7% in 2027. Energy prices are up nearly one-third this year. Grain shipment disruptions, adverse weather, and high fertilizer costs are adding to the pressure. Strait of Hormuz commodity traffic has remained below pre-war levels since the US-Iran conflict, and the World Bank’s forecast assumes no further escalation. If that assumption breaks, the bank flagged a food crisis risk on par with the early 2010s. (Learn more)
The largest active US bird flu outbreak is at Rose Acre Farms near Germantown, Illinois, where the USDA confirmed 934,600 birds culled on October 19. It is the second-largest egg-laying facility in the country. Since the current outbreak began in February 2022, more than 210 million birds have been slaughtered nationally. Retail egg prices average $2.27 per dozen now, well below the $6-plus peak from early 2025, but a single facility of this scale impacts regional supply and spot pricing before procurement teams can adjust contracts. A separate detection in a Washington dairy herd mid-October has another input category on high alert. (Learn more)
Kroger’s private label operation is now a $40 billion business with 35 manufacturing sites. Private Selection, its premium tier, brought in $2.9 billion in 2025 sales, with a target of $5 billion within three years. Its value tier, Smart Way, is adding 1,000 items. For branded manufacturers already facing input cost inflation, it’s getting harder to compete for shelf space. (Learn more)
GLP-1 demand is challenging production
GLP-1 is reshaping purchase behavior at a measurable scale. An EY-Parthenon survey of more than 3,600 current and former GLP-1 users found 66% are eating more fresh produce, 61% are eating more protein, 63% are cutting sweets, and 57% are cutting salty snacks. More than half are eating out less often. Adoption is expected to grow in the mid-20% range annually through 2030, driven primarily by falling drug prices and broader insurance coverage. Among current users, 42% have already lost interest in foods they previously enjoyed. (Learn more)
Danone correctly forecasted demand but failed to build adequate capacity, leading to operational fallout. Oikos and Activia surged amid demand for high-protein, portion-controlled yogurt. Danone’s US manufacturing capacity couldn’t keep up. Investment in a Fort Worth, Texas facility and an upgraded Minster, Ohio plant created supply chain disruptions and customer service failures across North America. The company named Francois Lacombe as US president to fix execution and retailer relationships heading into 2027. Q3 North America like-for-like sales rose 2.4%, but volume and mix fell 0.6% while price carried 3 points, meaning the growth is driven by price rather than demand. CFO Juergen Esser said 2027 needs to “look very different.” (Learn more)
Before your brand chases the same opportunity, focus on the operating sequence. A Fast Company analysis argues brands should research first, reposition second, and reformulate only when evidence demands it. Many manufacturers already make products that fit GLP-1 eating patterns, but they aren’t yet positioned as such. A consumer survey of 2,184 US adults found 10.4% currently take a GLP-1, with nearly 60% in the broader footprint of users, former users, and household members. That is a reachable audience with existing products. (Learn more)
